HCP5 and viral infectious disease: Various HCP5 variants are demonstrated to promote susceptibility to adverse immune-related cutaneous drug reactions, such as Stevens-Johnson syndrome, as well as being associated with disease progression and viral load in untreated patients with HIV, suggesting a possible specific role for HCP5 in modifying the immune response to medications or viral infections (38, 39).